Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AREC CVE:MPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARECAmerican Resources$2.11-11.3%$2.29$0.63▼$7.11$254.59M1.093.50 million shs4.51 million shsMPHMedicureC$1.08C$1.17C$0.85▼C$1.43C$11.27M0.5364732,932 shs5,600 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARECAmerican Resources-3.25%-1.24%+3.48%-24.20%+244.93%MPHMedicure-2.70%-2.70%-11.48%+11.34%+8.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARECAmerican Resources$2.11-11.3%$2.29$0.63▼$7.11$254.59M1.093.50 million shs4.51 million shsMPHMedicureC$1.08C$1.17C$0.85▼C$1.43C$11.27M0.5364732,932 shs5,600 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARECAmerican Resources-3.25%-1.24%+3.48%-24.20%+244.93%MPHMedicure-2.70%-2.70%-11.48%+11.34%+8.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARECAmerican Resources 2.80Moderate Buy$6.00184.36% UpsideMPHMedicure 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest AREC, FARN, MPH, and BVXP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/26/2026ARECAmerican Resources Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Hold (C-)4/20/2026ARECAmerican Resources Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARECAmerican Resources$380K593.97N/AN/A$0.92 per share2.29MPHMedicureC$31.32M0.36C$0.43 per share2.49C$1.21 per share0.89Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARECAmerican Resources$55.41M-$0.41N/A2.51N/A-27,532.48%N/A-8.48%6/5/2026 (Estimated)MPHMedicure-C$2.03M-C$0.65N/AN/AN/A-21.74%-44.51%-5.63%N/ALatest AREC, FARN, MPH, and BVXP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/5/2026Q4 2025ARECAmerican Resources-$0.09-$0.0950-$0.0050$0.75$1.00 million($0.10) million5/19/2026Q4 2025ARECAmerican ResourcesN/A$0.75N/A$0.75N/A($0.10) millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthARECAmerican ResourcesN/AN/AN/AN/AN/AMPHMedicureN/A2.24%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARECAmerican Resources0.142.192.19MPHMedicure6.341.041.29Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARECAmerican Resources9.32%MPHMedicure4.85%Insider OwnershipCompanyInsider OwnershipARECAmerican Resources1.81%MPHMedicure26.68%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARECAmerican Resources10106.97 million105.04 millionOptionableMPHMedicureN/A10.44 millionN/ANot OptionableAREC, FARN, MPH, and BVXP HeadlinesRecent News About These CompaniesMedicure (CVE:MPH) Share Price Passes Above 50 Day Moving Average - Should You Sell?June 3 at 3:39 AM | americanbankingnews.comMedicure Inc. (MPH:CA) Q4 2025 Earnings Call Prepared Remarks TranscriptApril 27, 2026 | seekingalpha.comMedicure, Inc.: Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference CallApril 24, 2026 | finanznachrichten.deMedicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference CallApril 23, 2026 | pharmiweb.comPMedicure's president and COO, Neil Owens to resign; CEO Albert Friesen to take over presidential dutiesApril 20, 2026 | msn.comMedicure, Inc.: Medicure Announces Resignation of President and Chief Operating OfficerApril 18, 2026 | finanznachrichten.deMedicure Inc. (MPH:CA) Q3 2025 Earnings Call TranscriptNovember 20, 2025 | seekingalpha.comMedicure Sees Revenue Growth Amidst Challenges in Q3 2025November 19, 2025 | msn.comHydro One, Loblaw, Medicure at 52-Week Highs on NewsNovember 18, 2025 | baystreet.caMedicure Inc. to Announce Q3 2025 Financial ResultsNovember 13, 2025 | tipranks.comMedicure Second Quarter 2025 Earnings: CA$0.08 loss per share (vs CA$0.12 loss in 2Q 2024)August 22, 2025 | finance.yahoo.comMedicure Inc. Reports Increased Revenue and Improved EBITDA for Q2 2025August 20, 2025 | tipranks.comMedicure to Present Financial Results on August 21…August 20, 2025 | pharmiweb.comPMedicure Inc. to Announce Q2 2025 Financial ResultsAugust 18, 2025 | tipranks.comMedicure, Inc.: Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia PharmacyJune 17, 2025 | finanznachrichten.deEarnings call transcript: Medicure reports Q1 2025 decline in revenue, steady stockMay 24, 2025 | uk.investing.comMedicure, Inc.: Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical PharmacyMarch 11, 2025 | finanznachrichten.deTyreek Hill was driving an estimated 60 mph in a 40 mph zone before hectic detainment incidentSeptember 12, 2024 | nypost.comNMedicure Inc. (NGQ1.F)August 21, 2024 | uk.finance.yahoo.comMedicure Inc. (MPH.V)August 12, 2024 | ca.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAREC, FARN, MPH, and BVXP Company DescriptionsAmerican Resources NASDAQ:AREC$2.11 -0.27 (-11.34%) Closing price 04:00 PM EasternExtended Trading$2.14 +0.03 (+1.42%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.American Resources Corporation, together with its subsidiaries, extracts, processes, transports, and sells metallurgical coal to the steel and industrial industries. It supplies raw materials; and sells coal used in pulverized coal injections. The company was founded in 2006 and is headquartered in Fishers, Indiana.Medicure CVE:MPHC$1.08 0.00 (0.00%) As of 06/4/2026 02:30 PM EasternMedicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below Five Below Down 12% Post Earnings—Is the Selloff Overdone? Buy the Dip? Broadcom's AI Moat Is Wider Than Ever The Market Has Ollie’s Bargain Outlet Completely Wrong Broadcom's Whiplash: Shares Tank After Pre-Earnings Surge Navitas: NVIDIA’s AI Power Broker? Macy's Delivers Strong Q1, Raises Outlook, but Wall Street Remains Cautious NVIDIA's New Power Play: Why Fluence Is Surging Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
